Ofer Haviv | President and Chief Executive Officer |
Amit Noam | Chief Executive Officer of Lavie Bio |
Eyal Ronen | Chief Executive Officer of Casterra |
Yaron Eldad | Chief Financial Officer |
Ben Klieve | Lake Street Capital Markets |
Brett Reiss | Janney Montgomery Scott |
Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Second Quarter 2023 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded on August 17, 2023.
Before we begin, I would like to caution that certain statements made during this earnings conference call by Evogene's management will constitute forward-looking statements that relate to future events, risks and uncertainties regarding business strategy, operations and future performance and results of Evogene. I encourage you to review Evogene's filings with the U.S.